Connective tissue diseases - Clinical Medicine Flashcards
(108 cards)
a) What is raynaud’s phenomenon?
b) What is it tirggered by?
c) What drug worsens raynaud’s?
d) What are the symptoms
e) Discuss the management
a) Raynauds phenomenon is caused by temporary spasm of blood vessels which block the flow of blood
b) Cold temperatures, anxiety, stress - can be primary or secondary
c)
- Fingers, toes, ears, nose, lips or nipples commonly affected
- Triphasic colour changes: white, blue and red
- Pain
- Numbness
- Pins and needles
- Digital ulceration (severe)
- Digital gangrene (severe)
d) Propanalol - beta blocker
e)
- Keep warm
- Stop smoking (can cause vasoconstriction of blood vessels, worseing Raynaud’s)
- 1st line - Calcium channel blocker (antihypetensive drug which relaxes muscle walls around blood vessels - helps encourage blood flow to peripheries)
- Iloprost (encourages blood flow but requires to be in hospital for 5 days - recommended for those with necrosis)
- Sildenafil/viagra (increases blood flow to peripheries - best for those who have ulcer as it prrevents healing and new ulcers forming)
- IV prostacyclin
What may you see on examination of someone’s with raynaud’s?
- Capillary nail-fold loops (and oil placed on the skin) can show loss of normal loop pattern
- Chrnoic ischaemia may lead to colour change
- Digital ulcers in severe disease
When would you consider secondary Raynaud’s?
- Age at onset over 25 years
- Absence of a family history of Raynaud’s phenomenon
- Male patient
Describe the epidemiology of SLE
- More prevalent in afro-carribeans than caucasians
- More common in females (90% of affected patients are female)
- Peak age of onset is between 20 and 30 years
Discuss the aetiology of SLE
- There are genetic, environmental and hormonal factors thought to be important to the aetiology
- SLE can be induced by drugs e.g., minocycline, hydralazine, and the oral contraceptive pill (drug-induced lupus tends to be mild and does not affect the kidneys)
- Oestrogen is thought to play a role in producing autoreactive B cells
- Environmental triggers include viruses and UV B-light
Give 5 factors that trigger flares of SLE
- Overexposure to sunlight: UV light B > A
- Oestrogen-containing contraceptic therapy
- Drug e.g., hyrdalazine (BP), minocycline (susceptible infections), carbamzepine (epilepsy), chlorpromazine (psychosis), isoniazid (TB), methyldopa (BP) and sulphasalazine (RhA)
- Infection
- Stress
Give 7 drugs that can trigger flares of SLE
- Hyrdalazine (BP)
- Minocycline (susceptible infections)
- Carbamzepine (epilepsy)
- Chlorpromazine (psychosis)
- Isoniazid (TB)
- Methyldopa (BP)
- Sulphasalazine (RhA)
Desrcibe the clinical features of SLE
- Variable
- Systemic features
* Fever, weight loss, mild lymphadenopathy, fatigue and arthralgia - Joints
- Arthralgia with early morning stiffness
- Synovitis (rare)
- Jaccoud’s arthropathy - rheumatoid hands that are reducible in extension
- Raynaud’s phenomenon
- Dermatological features
- Butterly malar rash on cheeks and nose
- Discoid rash
- Diffuse and non-scarring alopecia (hair loss)
- Urticaria (red, itchy welts that result from a skin reaction)
- Livedo reticularis (refers to a netlike pattern of reddish-blue skin discoloration)
- Renal features
- Hallmark of severe disease
- Proliferative glomerulonephritis - most common cause of lupus-realted death
- Presents with heavy haematuria, proteinuria and casts on urine microscopy
- Cardiovascular features
- Heart - pericarditis, myocarditis and Libman-Sacks endocarditis (sterile vegetations - inflammation seen on valves of the heart)
- Arteries - atherosclerosis greatly increased, increasing chances of a stroke and myocardial infarction
- Raynaud’s phenomenon
- Vasculitis
- Pulmonary features
- Pleuritic pain (serositis) or pleural effusion (fluid inside of lungs as a result of inflamed lining of the cell)
- Less common: pneymonitis, ateletasis, reduced lung volume and pulmonary fibrosis that leads to breathlessness
- Increased risk of thromboembolism (DVT, pulmonary embolism), especially if antiphospholipid antibodies present
- Neurological
- Headache and poor concentration are common
- Less common: visual hallucinations, chorea (a movement disorder that causes involuntary, irregular, unpredictable muscle movements), organic psychosis, transverse myelitis and lymphocytic meningitis
- Neuropsychiatric e.g., seizures, stroke, movement disorder, transverse myelitis, cranial neuropathy, peripheral neuropathy, psychosis, anxiety, depression
- GI tract
- Mouth/nose/genital
- Peritoneal serositis (inflammation of lining of abdominal cavity) can cause acute pain
- Mesentric vasculitis is serious (abdominal pain, bowel infarction or perforation)
- Hepatitis is rare
- Haematological abnormalitis
- Neutropenia
- Lymphopenia
- Thromobocytopenia
- Haemolytic anaemia
Describe the late complications of SLE
- Glomerulonephritis - end stage renal disease, dialysis and transplantation
- Vasculitis - atherosclerosis, pulmonary embolism
- Arthritis - osteonecrosis
- (Cerbral lupus) Cerebritis - neuropsychiatric dysfunction e.g., fits, psychosis, raised ESR and anti-dsDNA titre, low complement C3 and C4
- Pneumonitis - shrinking lung syndrome
Lupus glomerulonephritis and cerebral lupus are the two main emergencies in SLE
a) Describe the clinical symptoms, treatment and prevention of lupus glomerulonephritis
b) Describe the clinical features, signs and treatment of cerebra lupus
- Lupus glomerulonephritis
- Clinical features - nephritis (proteinuria, hypoalbuminemia and oedema)
- Treatment - high dose steroids plus immunosuppression
- Prevention - urinalysis to assess for proteinuria
- Cerebral lupus
* Clinical features - different presentations e.g., fits, psychosis, severe unremitting headaches or impairment of consciousness + other signs of active SLE disease.
Signs: ESR and anti ds-DNA antibody titres will be raised whereas the complement C3 and C4 levels will be low. The C-Reactive Protein (CRP) levels will often not be markedly raised. Sometimes, the blood markers of active SLE disease and the MRI scan can be normal.
Treatment- high dose steroids and immunosuppression (Cyclophosphamide/Azathioprine).
How are kidneys in patient with SLE monitored?
Regular urinalysis and blood pressure monitoring is essential
a) What factors can lead to neonatal lupus in babies?
b) What are the symptoms
a)
- Pregnancy loss
- Preterm birth
b)
- Pericardial effusion and conduction effects
- Skin rash

Name the diagnostic criteria for SLE
Presence of ≥4 supports the diagnosis:
A RASH POINTs MD
- Arthritis/arthralgia
- Renal disease
- ANA +ve
- Serosits (pericardits/pleurisy/pleural effusion)
- Haemotological (haemolysis/low WCC/platelets/lymphocytes)
- Photosensitivity rash
- Oral ulcers
- Immunological tests positive (anti-dsDNA/anti-Sm,anti-phospholipid)
- Neuropsychiatric (seizures, migraines, psyhosis)
- Malar rash
- Discoid rash
Describe the initial investigations andother investigations undertaken for SLE and the findings
Initial investigations
- Immunological (Autoantibodies) e.g., ANA, anti-Ro/La, anti-DsDNA may be detected
- U+E’s and urinalysis - look for haematuria and proteinuria which are signs of nephritis
- FBC - look for anaemia, leukopenia, thrombocytopenia
- ESR- high during flare up
- CRP- normal/mildly elevated unless infection, synovitis or serositis present
- Complement levels (C3 and C4) - lower in SLE
Other investigations
- Plain X-rays - show inflammation of affected joints
- Coombs test - positive in patients with autoimmune haemolytic anaemia
- Skin biopsy - shows deposition of IgG and complement at the dermal–epidermal junction in patients with rashes (lupus band test)
- Renal biopsy - sometimes performed to aid diagnosis or to establish prognosis in patients with abnormal renal function + most sensitive and specific test for lupus nephritis
- Brain MRI - patients with suspected cerebral lupuss
- Echocardiogram - can show pericarditis, pericardial effusion, pulmonary hypertension
- Pulmonary function tests - show a restrictive pattern
- Pleural aspiration - may be performed in patients to identify cause of pleural effusion and shows exudate
a) What is the main autoantibody associated with SLE
b) What other autoantibodies is SLE associated with?List the autoantibodies associated with SLE
a) Anti-nuclear antibodies (ANA) - detected in >95% patients
b)
- Anti-Ro and anti-La antibodiees
- Anti-dsDNA antibodies
- Antihistone antibodies (+ve in drug-induced SLE)
- Antiphospholipid and anticardiollpin antibodies
List the 6 immmunological SLICC (Systemic lupus international collaborating clinics) classification criteria for SLE
- ANA
- Anti-DNA
- Anti-Sm
- Antiphospholipid Antibody
- Low complement (C3, C4, CH50)
- Direct Coomb’ test (do not count in the presence of hemolytic anaemia)

Describe the management of lupus
- Educate the patient - control symptoms to prevent organ damage and maintain normal function
- Avoid sun exposure and use sun block (spf 50), avoid oestrogen containing contraceptive pill
- Medicines - NSAIDs and hydroxychlorquine for mild disease, long-term corticosteroids for prominent organ involvement, high dose corticosteroids and immunosuppressants - usually cyclophosphamide for severe flares that cause serious renal, neurological or haematological effects
Name drug therapies that can be given to treat skin and joint disorder in SLE
- NAIDs + hydroxycholoquine (also protective against heart)
- Prednisolone
- Mycophenolate mofetil (immunosuppressant)
- Methotrexate
- Azathioprine
- Belimumab (monoclonal antibody targets the β-cell growth factor BLyS)
Name drug therapies (aggressive treatment) that can be given to treat end organ disease SLE
- High-dose glucocorticoids and immunosuppresants
- IV methylprednisolone (10mg/kg IV) plus IV cyclophosphamide for six cycles
- Rituximab and belimumab may benefit in some (used in refractory lupus)
Describe maintenance therapy of SLE
- Taper prednisolone - long term low dose
- Immunosuppresants - azathioprine, methotrextae, mycophenolate mofetil (MMF)
- Address cardiovascular risk factors
- Patients should be advised to stop smoking
- Anticoagulation with warfarin if thrombosis and antiphospholipid antibody syndrome
- Assess risk of osteoporosis and hypovitaminosis D
Which rheumatological conditions are known to frequently occur secondary to SLE?
- Secondary Sjogren’s syndrome.
- Secondary anti-phospholipid syndrome.
- Mixed connective tissue disease (features of SLE, systemic sclerosis and poly/dermatomyositis).
a) What is antiphospholipid syndrome (APS)
b) Name 3 things it is associated with
a) The antiphospholipid syndrome (APS) is a systemic autoimmune condition characterized by arterial and venous thrombosis, fetal loss and thrombocytopenia associated with persistent levels of antiphospholipid antibodies.
b)
- SLE
- Repeated miscarriages
- Fetal death
Describe the clinical features of antiphospholipid syndrome
Major features
- Venous thrombosis - DVT and pulmonary emboli
- Arterial thrombosis - cerebral ischaemia and periperal sichaemia
- Fetal complications - spontaneous abortion, premature births
- Thrombocytopenia
Associated clinical features
- Livdeo reticularis
- Leg ulcers
- Cardiac valve abnormalities
- Chorea
- Epilepsy
- Migrane
- Haemolytic anaemia
What are the antibodies associated with anti-phospholid syndrome?
- Anti-cardiolipin
- Lupus anticoagulant
- Anti-beta 2 glycoprotein-1



